In addition, NLRP3 has been reported to be aberrantly upregulated in various tumor tissues, especially in the highly invasive subtype [18], indicating that the NLRP3 inflammasome may be associated with cancer progression, prognosis, and response to treatment [36, 37]. This evidence concerns the gene NLRP3 and cancer.